Literature DB >> 20690826

Kawasaki disease: novel insights into etiology and genetic susceptibility.

Anne H Rowley1.   

Abstract

Kawasaki disease (KD) is a vasculitis of young childhood that particularly affects the coronary arteries. Molecular analysis of the oligoclonal IgA response in acute KD led to production of synthetic KD antibodies. These antibodies identify intracytoplasmic inclusion bodies in acute KD tissues. Light and electron microscopic studies indicate that the inclusion bodies are consistent with aggregates of viral proteins and RNA. Advances in molecular genetic analysis and completion of the Human Genome Project have sparked a worldwide effort to identify genes associated with KD. A polymorphism of one such gene, ITPKC, a negative regulator of T cell activation, confers susceptibility to KD in Japanese populations and increases the risk of developing coronary artery abnormalities in both Japanese and U.S. children. Identification of the etiologic agent and of genes conferring KD susceptibility are the best means of improving diagnosis and therapy and enabling prevention of this important disorder of childhood.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20690826      PMCID: PMC3021097          DOI: 10.1146/annurev-med-042409-151944

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  47 in total

1.  IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.

Authors:  A H Rowley; C A Eckerley; H M Jäck; S T Shulman; S C Baker
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

2.  Clonal expansion of CD8+ T cells in Kawasaki disease.

Authors:  I H Choi; Y J Chwae; W S Shim; D S Kim; D H Kwon; J D Kim; S J Kim
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Kawasaki disease and rug shampoo.

Authors:  K Ohga; R Yamanaka; H Kinumaki; S Awa; N Kobayashi
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

5.  Kawasaki syndrome: association with the application of rug shampoo.

Authors:  P A Patriarca; M F Rogers; D M Morens; L B Schonberger; R M Kaminski; J C Burns; M P Glode
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

6.  Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease.

Authors:  L Mancia; J Wahlström; B Schiller; L Chini; G Elinder; P D'Argenio; D Gigliotti; H Wigzell; P Rossi; J Grunewald
Journal:  Scand J Immunol       Date:  1998-10       Impact factor: 3.487

7.  Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells.

Authors:  M Sakaguchi; H Kato; A Nishiyori; K Sagawa; K Itoh
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

8.  Evidence for a superantigen mediated process in Kawasaki disease.

Authors:  N Curtis; R Zheng; J R Lamb; M Levin
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

9.  TCR V beta family repertoire and T cell activation markers in Kawasaki disease.

Authors:  B A Pietra; J De Inocencio; E H Giannini; R Hirsch
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

10.  Kawasaki syndrome: description of two outbreaks in the United States.

Authors:  D M Bell; E W Brink; J L Nitzkin; C B Hall; H Wulff; I D Berkowitz; P M Feorino; R C Holman; C L Huntley; R H Meade; L J Anderson; S H Cheeseman; N J Fiumara; R F Gilfillan; D E Keim; J F Modlin
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

View more
  41 in total

1.  Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies.

Authors:  Virginia E Pitzer; David Burgner; Cécile Viboud; Lone Simonsen; Viggo Andreasen; Claudia A Steiner; Marc Lipsitch
Journal:  Proc Biol Sci       Date:  2012-03-07       Impact factor: 5.349

Review 2.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

3.  Diagnostic potential of antibody titres against Candida cell wall β-glucan in Kawasaki disease.

Authors:  K Ishibashi; R Fukazawa; N N Miura; Y Adachi; S Ogawa; N Ohno
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.

Authors:  Xavier Rodó; Roger Curcoll; Marguerite Robinson; Joan Ballester; Jane C Burns; Daniel R Cayan; W Ian Lipkin; Brent L Williams; Mara Couto-Rodriguez; Yosikazu Nakamura; Ritei Uehara; Hiroshi Tanimoto; Josep-Anton Morguí
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 5.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

6.  Kawasaki's disease and onychomadesis in a 17-month-old girl with non-SARS-CoV2 coronavirus.

Authors:  Juliana L Pineider; Isabel Mary Haugh; Claudio Ramaciotti; Nnenna Gebechi Agim
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-01-11

7.  A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis.

Authors:  Jiao Lou; Sanqing Xu; Li Zou; Rong Zhong; Ti Zhang; Yu Sun; Xuzai Lu; Li Liu; Chuanqi Li; Li Wang; Guanglian Xiong; Wei Wang; Fangqi Gong; Jing Wu
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

8.  Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.

Authors:  G Bossi; S Mannarino; M C Pietrogrande; P Salice; R M Dellepiane; A L Cremaschi; G Corana; A Tozzo; C Capittini; A De Silvestri; C Tinelli; A Pasi; M Martinetti
Journal:  Genes Immun       Date:  2015-09-03       Impact factor: 2.676

9.  Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.

Authors:  Daiko Wakita; Yosuke Kurashima; Timothy R Crother; Magali Noval Rivas; Youngho Lee; Shuang Chen; Wen Fury; Yu Bai; Shawn Wagner; Debiao Li; Thomas Lehman; Michael C Fishbein; Hal M Hoffman; Prediman K Shah; Kenichi Shimada; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

10.  [Association of rs4638289 and rs7131332 polymorphisms of the serum amyloid A1 gene with Kawasaki disease].

Authors:  Ying Chen; Cheng Wang; Qing Ji; Juan Zhang; Cheng Tan; Shuang-Shuang Wang; Xiu-Ying Yi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.